{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:38:05Z","timestamp":1792179485717,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Fujian Provincial Science and Technology Department","award":["2018J01405"],"award-info":[{"award-number":["2018J01405"]}]},{"name":"Natural Science Foundation of Fujian Provincial Science and Technology Department","award":["2019J01617"],"award-info":[{"award-number":["2019J01617"]}]},{"name":"Guangdong Provincial People's Hospital Foundation","award":["DFJH201919"],"award-info":[{"award-number":["DFJH201919"]}]},{"name":"Beijing Lisheng Cardiovascular Health Foundation","award":["LHJJ20141751"],"award-info":[{"award-number":["LHJJ20141751"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670339"],"award-info":[{"award-number":["81670339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The platelet-to-hemoglobin ratio (PHR) has emerged as a prognostic biomarker in coronary artery disease (CAD) patients after PCI but not clear in CAD complicated with congestive heart failure (CHF). Hence, we aimed to assess the association between PHR and long-term all-cause mortality among CAD patients with CHF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the registry at Guangdong Provincial People\u2019s Hospital in China, we analyzed data of 2599 hospitalized patients who underwent coronary angiography (CAG) and were diagnosed with CAD complicated by CHF from January 2007 to December 2018. Low PHR was defined as \u02c2 1.69 (group 1) and high PHR as\u2009\u2265\u20091.69 (group 2). Prognosis analysis was performed using Kaplan\u2013Meier method. To assess the association between PHR and long-term all-cause mortality, a Cox-regression model was fitted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 5.2 (3.1\u20137.8) years, a total of 985 (37.9%) patients died. On the Kaplan\u2013Meier analysis, patients in high PHR group had a worse prognosis than those in low PHR group (log-rank,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0011). After adjustment for confounders, high PHR was correlated with an increased risk of long-term all-cause mortality in CAD patients complicated with CHF. (adjusted hazard ratio [aHR], 1.31; 95% confidence interval [CI], 1.13\u20131.52,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated PHR is correlated with an increased risk of long-term all-cause mortality in CAD patients with CHF. These results indicate that PHR may be a useful prognostic biomarker for this population. Meanwhile, it is necessary to take effective preventive measures to regulate both hemoglobin levels and platelet counts in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-021-02423-6","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T21:02:28Z","timestamp":1640638948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure"],"prefix":"10.1186","volume":"21","author":[{"given":"Kunming","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"issue":"11","key":"2423_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/CIRCULATIONAHA.106.623199","volume":"114","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114(11):1202\u201313.","journal-title":"Circulation"},{"issue":"3","key":"2423_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijcard.2013.12.019","volume":"171","author":"N Shah","year":"2014","unstructured":"Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, Rathod A, Lafferty J. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014;171(3):390\u20137.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2423_CR3","doi-asserted-by":"publisher","first-page":"10639","DOI":"10.1038\/s41598-019-47143-2","volume":"9","author":"GL Ye","year":"2019","unstructured":"Ye GL, Chen Q, Chen X, Liu YY, Yin TT, Meng QH, Liu YC, Wei HQ, Zhou QH. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: a cohort study. Sci Rep. 2019;9(1):10639.","journal-title":"Sci Rep"},{"issue":"22","key":"2423_CR4","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1093\/eurheartj\/ehl305","volume":"27","author":"I Chung","year":"2006","unstructured":"Chung I, Lip GY. Platelets and heart failure. Eur Heart J. 2006;27(22):2623\u201331.","journal-title":"Eur Heart J"},{"issue":"3","key":"2423_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/01.CIR.60.3.497","volume":"60","author":"J Mehta","year":"1979","unstructured":"Mehta J, Mehta P. Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside. Circulation. 1979;60(3):497\u2013503.","journal-title":"Circulation"},{"issue":"4","key":"2423_CR6","first-page":"852","volume":"98","author":"R Iijima","year":"2007","unstructured":"Iijima R, Ndrepepa G, Mehilli J, Bruskina O, Schulz S, Sch\u00f6mig A, Kastrati A. Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemostasis. 2007;98(4):852\u20137.","journal-title":"Thromb Haemostasis"},{"issue":"2","key":"2423_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis\u2014an inflammatory disease. N Engl J Med. 1999;340(2):115\u201326.","journal-title":"N Engl J Med"},{"issue":"5","key":"2423_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","volume":"27","author":"G Torre-Amione","year":"1996","unstructured":"Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996;27(5):1201\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2423_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1089\/10799900260286623","volume":"22","author":"MH Klinger","year":"2002","unstructured":"Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interf Cytokine Res. 2002;22(9):913\u201322.","journal-title":"J Interf Cytokine Res"},{"issue":"2","key":"2423_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","volume":"107","author":"JA Ezekowitz","year":"2003","unstructured":"Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107(2):223\u20135.","journal-title":"Circulation"},{"issue":"23","key":"2423_CR11","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.ehj.2003.09.008","volume":"24","author":"H Reinecke","year":"2003","unstructured":"Reinecke H, Trey T, Wellmann J, Heidrich J, Fobker M, Wichter T, Walter M, Breithardt G, Schaefer RM. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J. 2003;24(23):2142\u201350.","journal-title":"Eur Heart J"},{"issue":"5","key":"2423_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/01.CIR.74.5.1085","volume":"74","author":"AS Most","year":"1986","unstructured":"Most AS, Ruocco NA Jr, Gewirtz H. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation. 1986;74(5):1085\u201392.","journal-title":"Circulation"},{"issue":"4","key":"2423_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/hrt.70.4.357","volume":"70","author":"IS Anand","year":"1993","unstructured":"Anand IS, Chandrashekhar Y, Ferrari R, Poole-Wilson PA, Harris PC. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J. 1993;70(4):357\u201362.","journal-title":"Br Heart J"},{"key":"2423_CR14","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1046\/j.1523-1755.64.s87.6.x","volume":"87","author":"AA Pereira","year":"2003","unstructured":"Pereira AA, Sarnak MJ. Anemia as a risk factor for cardiovascular disease. Kidney Int Suppl. 2003;87:S32-39.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"2423_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","volume":"110","author":"I Anand","year":"2004","unstructured":"Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110(2):149\u201354.","journal-title":"Circulation"},{"issue":"19","key":"2423_CR16","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1177\/2047487319870346","volume":"27","author":"YY Zheng","year":"2020","unstructured":"Zheng YY, Wu TT, Chen Y, Hou XG, Yang Y, Zhang JY, Ma YT, Xie X. Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study. Eur J Prev Cardiol. 2020;27(19):2216\u20139.","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"2423_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIR.0b013e318256f1e0","volume":"126","author":"H Jneid","year":"2012","unstructured":"Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, et al. 2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2012;126(7):875\u2013910.","journal-title":"Circulation"},{"issue":"10","key":"2423_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","volume":"67","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, et al. 2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary Intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016;67(10):1235\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2423_CR19","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2423_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","volume":"39","author":"GM Felker","year":"2002","unstructured":"Felker GM, Shaw LK, O\u2019Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39(2):210\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2423_CR21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/hrt.2005.066464","volume":"92","author":"L Purek","year":"2006","unstructured":"Purek L, Laule-Kilian K, Christ A, Klima T, Pfisterer ME, Perruchoud AP, Mueller C. Coronary artery disease and outcome in acute congestive heart failure. Heart (Br Cardiac Soc). 2006;92(5):598\u2013602.","journal-title":"Heart (Br Cardiac Soc)"},{"issue":"1","key":"2423_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/eurjhf\/hfs139","volume":"15","author":"RJ Mentz","year":"2013","unstructured":"Mentz RJ, Allen BD, Kwasny MJ, Konstam MA, Udelson JE, Ambrosy AP, Fought AJ, Vaduganathan M, O\u2019Connor CM, Zannad F, et al. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. Eur J Heart Fail. 2013;15(1):61\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"2423_CR23","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","volume":"379","author":"F Zannad","year":"2018","unstructured":"Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med. 2018;379(14):1332\u201342.","journal-title":"N Engl J Med"},{"issue":"16","key":"2423_CR24","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810\u201352.","journal-title":"Circulation"},{"issue":"25","key":"2423_CR25","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","volume":"101","author":"MG Sutton","year":"2000","unstructured":"Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101(25):2981\u20138.","journal-title":"Circulation"},{"issue":"5","key":"2423_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.104.486720","volume":"112","author":"RA Levine","year":"2005","unstructured":"Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005;112(5):745\u201358.","journal-title":"Circulation"},{"issue":"3","key":"2423_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jacc.2008.08.072","volume":"53","author":"JD Flaherty","year":"2009","unstructured":"Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, Liu PP, Konstam MA, Greenberg B, Mehra MR, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009;53(3):254\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2423_CR28","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, K\u00f8ber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349(20):1893\u2013906.","journal-title":"N Engl J Med"},{"issue":"3","key":"2423_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4065\/84.3.289","volume":"84","author":"BA Koplan","year":"2009","unstructured":"Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009;84(3):289\u201397.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2423_CR30","doi-asserted-by":"publisher","first-page":"e13973","DOI":"10.1111\/ijcp.13973","volume":"75","author":"M Oylumlu","year":"2021","unstructured":"Oylumlu M, Oylumlu M, Arik B, Demir M, Ozbek M, Arslan B, Acun B, Polat N, Akil MA, Bilik MZ. Monocyte to high-density lipoprotein cholesterol and lymphocyte to monocyte ratios are predictors of in-hospital and long-term mortality in patients with acute coronary syndrome. Int J Clin Pract. 2021;75(5):e13973.","journal-title":"Int J Clin Pract"},{"issue":"10","key":"2423_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0003319720943810","volume":"71","author":"Z Qiu","year":"2020","unstructured":"Qiu Z, Jiang Y, Jiang X, Yang R, Wu Y, Xu Y, Cheng X. Relationship between platelet to lymphocyte ratio and stable coronary artery disease: meta-analysis of observational studies. Angiology. 2020;71(10):909\u201315.","journal-title":"Angiology"},{"issue":"7","key":"2423_CR32","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.amjcard.2014.07.005","volume":"114","author":"A Kurtul","year":"2014","unstructured":"Kurtul A, Murat SN, Yarlioglues M, Duran M, Ergun G, Acikgoz SK, Demircelik MB, Cetin M, Akyel A, Kasapkara HA, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol. 2014;114(7):972\u20138.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2423_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.COC.0000017093.79897.DE","volume":"26","author":"MG Alexandrakis","year":"2003","unstructured":"Alexandrakis MG, Passam FH, Moschandrea IA, Christophoridou AV, Pappa CA, Coulocheri SA, Kyriakou DS. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003;26(2):135\u201340.","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"2423_CR34","doi-asserted-by":"publisher","first-page":"e67688","DOI":"10.1371\/journal.pone.0067688","volume":"8","author":"T Gary","year":"2013","unstructured":"Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, Eller P, Rief P, Hackl G, Pilger E, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLOS ONE. 2013;8(7):e67688.","journal-title":"PLOS ONE"},{"issue":"4","key":"2423_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/0003319715591751","volume":"67","author":"EH Ozcan Cetin","year":"2016","unstructured":"Ozcan Cetin EH, Cetin MS, Aras D, Topaloglu S, Temizhan A, Kisacik HL, Aydogdu S. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology. 2016;67(4):336\u201345.","journal-title":"Angiology"},{"issue":"3","key":"2423_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/107602960300900301","volume":"9","author":"S Tsiara","year":"2003","unstructured":"Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb\/Hemost. 2003;9(3):177\u201390.","journal-title":"Clin Appl Thromb\/Hemost"},{"issue":"2","key":"2423_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0735-1097(97)00510-X","volume":"31","author":"MI Furman","year":"1998","unstructured":"Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31(2):352\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2423_CR38","first-page":"248","volume":"102","author":"LK Jennings","year":"2009","unstructured":"Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102(2):248\u201357.","journal-title":"Thromb Haemost"},{"issue":"12","key":"2423_CR39","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.amjcard.2016.03.034","volume":"117","author":"G Giustino","year":"2016","unstructured":"Giustino G, Kirtane AJ, Baber U, G\u00e9n\u00e9reux P, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger C, et al. Impact of anemia on platelet reactivity and ischemic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study. Am J Cardiol. 2016;117(12):1877\u201383.","journal-title":"Am J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02423-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T21:06:51Z","timestamp":1640639211000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02423-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2423"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02423-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-668943\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols of this study were approved by the institutional Ethics Research Committee of Guangdong Provincial People\u2019s Hospital (No. GDREC2019555H). The study was performed according to the declaration of Helsinki. Written informed consent for this study was also waived by the Guangdong Provincial People\u2019s Hospital Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"618"}}